Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Tax Provisions (2016 - 2026)

Pharma-Bio Serv filings provide 17 years of Tax Provisions readings, the most recent being $3630.0 for Q1 2026.

  • On a quarterly basis, Tax Provisions rose 225.56% to $3630.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $18276.0, a 76.78% increase, with the full-year FY2025 number at $6203.0, down 72.02% from a year prior.
  • Tax Provisions hit $3630.0 in Q1 2026 for Pharma-Bio Serv, down from $4356.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $168040.0 in Q2 2023 to a low of -$30960.0 in Q4 2024.
  • Median Tax Provisions over the past 5 years was $19004.0 (2024), compared with a mean of $35326.4.
  • Biggest five-year swings in Tax Provisions: skyrocketed 273.36% in 2023 and later crashed 4406.55% in 2024.
  • Pharma-Bio Serv's Tax Provisions stood at $57665.0 in 2022, then tumbled by 101.19% to -$687.0 in 2023, then crashed by 4406.55% to -$30960.0 in 2024, then soared by 114.07% to $4356.0 in 2025, then decreased by 16.67% to $3630.0 in 2026.
  • The last three reported values for Tax Provisions were $3630.0 (Q1 2026), $4356.0 (Q4 2025), and $4779.0 (Q3 2025) per Business Quant data.